Want to see SNN full AI Analyst Report?
Operating Income by Segment
Shows the profitability of each business segment, highlighting which areas are driving earnings and which may require strategic adjustments.Smith & Nephew Snats is experiencing a significant decline in operating income across all segments by the end of 2024, with Orthopaedics and Sports Medicine & ENT seeing the most notable drops. This downturn could indicate challenges in maintaining profitability, possibly due to increased competition or operational inefficiencies. The Corporate & Other segment, however, shows a reduction in losses, which might suggest cost-cutting measures or improved financial management. Investors should watch for strategic shifts or management commentary to understand potential recovery paths.
Date | Orthopaedics | Sports Medicine & ENT | Advanced Wound Management | Corporate & Other |
|---|---|---|---|---|
Dec 31, 2024 | $73.00M | $162.00M | $184.00M | -$90.00M |
Jun 29, 2024 | $192.00M | $275.00M | $215.00M | -$354.00M |
Dec 31, 2023 | $224.00M | $279.00M | $249.00M | -$602.00M |
Jul 01, 2023 | $174.00M | $224.00M | $223.00M | -$346.00M |
Dec 31, 2022 | $190.00M | $245.00M | $219.00M | -$446.00M |
Jul 02, 2022 | $193.00M | $227.00M | $217.00M | -$395.00M |
Dec 31, 2021 | $163.00M | $245.00M | $246.00M | -$300.00M |
Jul 03, 2021 | $204.00M | $214.00M | $228.00M | -$407.00M |
Dec 31, 2020 | $269.00M | $199.00M | $209.00M | -$377.00M |
Jun 27, 2020 | $120.00M | $107.00M | $107.00M | -$339.00M |